Singapore markets open in 1 hour 30 minutes

CHRS Aug 2022 10.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.15000.0000 (0.00%)
As of 01:10PM EDT. Market open.
Full screen
Previous close0.1500
Open0.1500
Bid0.0000
Ask0.3500
Strike10.00
Expiry date2022-08-19
Day's range0.1500 - 0.1500
Contract rangeN/A
Volume10
Open interest315
  • Motley Fool

    Coherus BioSciences (CHRS) Q2 2022 Earnings Call Transcript

    This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K. Today's call includes forward-looking statements regarding Coherus' current expectations about future events. All these forward-looking statements involve substantial risks and uncertainties that are beyond our control and could cause actual results, performance or achievements to differ from results, performance or achievements implied by the forward-looking statements.

  • Zacks

    Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates

    Coherus BioSciences (CHRS) delivered earnings and revenue surprises of 32.29% and 3.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Wall Street Analysts Predict an 85% Upside in Coherus BioSciences (CHRS): Here's What You Should Know

    The consensus price target hints at an 84.6% upside potential for Coherus BioSciences (CHRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.